These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2888905)

  • 1. Long-term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testes.
    Hadziselimović F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    J Urol; 1987 Oct; 138(4 Pt 2):1043-5. PubMed ID: 2888905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cryptorchidism with low doses of buserelin over a 6-months period.
    Hadziselimovic F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S56-8. PubMed ID: 2891526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of unilateral cryptorchid boys risking infertility with LH-RH analogue.
    Hadziselimovic F
    Int Braz J Urol; 2008; 34(3):319-26; discussion 327-8. PubMed ID: 18601762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin.
    Bica DT; Hadziselimovic F
    Eur J Pediatr; 1993; 152 Suppl 2():S38-42. PubMed ID: 8101813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life.
    Hadziselimović F; Herzog B
    J Urol; 1997 Sep; 158(3 Pt 2):1193-5. PubMed ID: 9258170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study.
    Bica DT; Hadziselimovic F
    J Urol; 1992 Aug; 148(2 Pt 2):617-21. PubMed ID: 1353540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undescended testis histology correlation with adult hormone levels and semen analysis.
    Kraft KH; Canning DA; Snyder HM; Kolon TF
    J Urol; 2012 Oct; 188(4 Suppl):1429-35. PubMed ID: 22906677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cryptorchid boys risking sterility and results of long-term buserelin treatment after successful orchiopexy.
    Hadziselimovic F; Herzog B; Höcht B; Hecker E; Miescher E; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S59-62. PubMed ID: 2891527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin may reduce the risk of germ cell loss in boys with cryptorchidism.
    Cortes D; Visfeldt J; Thorup JM
    Horm Res; 2001; 55(1):41-5. PubMed ID: 11423742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral undescended testes classified according to preoperative and postoperative status of gonadotropins and inhibin B in relation to testicular histopathology at bilateral orchiopexy in infant boys.
    Thorup J; Petersen BL; Kvist K; Cortes D
    J Urol; 2012 Oct; 188(4 Suppl):1436-42. PubMed ID: 22906669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and postoperative status of gonadotropins (FSH and LH) and inhibin-B in relation to testicular histopathology at orchiopexy in infant boys with unilateral undescended testes.
    Thorup J; Clasen-Linde E; Thorup SC; Cortes D
    J Pediatr Urol; 2015 Feb; 11(1):25.e1-5. PubMed ID: 25267218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between adult dark spermatogonia and secretory capacity of Leydig cells in cryptorchidism.
    Zivkovic D; Bica DT; Hadziselimovic F
    BJU Int; 2007 Nov; 100(5):1147-9; discussion 1149. PubMed ID: 17662083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between adult dark spermatogonia and other parameters of fertility potential in cryptorchid testes.
    Thorup J; Kvist K; Clasen-Linde E; Petersen BL; Cortes D
    J Urol; 2013 Oct; 190(4 Suppl):1566-71. PubMed ID: 23357211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study of cryptorchidism in children: testicular volume and hormonal function at 18 years of age.
    Varela-Cives R; Mendez-Gallart R; Estevez-Martinez E; Rodriguez-Barca P; Bautista-Casasnovas A; Pombo-Arias M; Tojo-Sierra R
    Int Braz J Urol; 2015; 41(1):57-66. PubMed ID: 25928530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal therapy for the subfertility of cryptorchidism.
    Huff DS; Snyder HM; Rusnack SL; Zderic SA; Carr MC; Canning DA
    Horm Res; 2001; 55(1):38-40. PubMed ID: 11423741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.
    Rajfer J; Handelsman DJ; Swerdloff RS; Hurwitz R; Kaplan H; Vandergast T; Ehrlich RM
    N Engl J Med; 1986 Feb; 314(8):466-70. PubMed ID: 2868413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LHRH and cryptorchidism.
    Frick J
    Eur J Pediatr; 1993; 152 Suppl 2():S28-30. PubMed ID: 8101808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testis histopathology in boys with cryptorchidism correlates with future fertility potential.
    Rusnack SL; Wu HY; Huff DS; Snyder HM; Carr MC; Bellah RD; Zderic SA; Canning DA
    J Urol; 2003 Feb; 169(2):659-62. PubMed ID: 12544338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinological studies in undescended testes.
    Waaler PE
    Acta Paediatr Scand; 1976 Sep; 65(5):559-64. PubMed ID: 8950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LHRH treatment in unilateral cryptorchidism: effect on testicular descent and hormonal response.
    Karpe B; Eneroth P; Ritzén EM
    J Pediatr; 1983 Dec; 103(6):892-7. PubMed ID: 6139422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.